Found 6 results. Export: Tagged | XML
Filters: keyword is Piperazines  [Clear All Filters]
2007
Zuideveld, K.P., Van der Graaf, P.H., Peletier, L.A., Danhof, M. , Allometric scaling of pharmacodynamic responses: application to 5-Ht1A receptor mediated responses from rat to man, Pharm Res, vol. 24, no. 11, pp. 2031-9. DOI
2002
Zuideveld, K.P., van Gestel, A., Peletier, L.A., Van der Graaf, P.H., Danhof, M. , Pharmacokinetic-pharmacodynamic modelling of the hypothermic and corticosterone effects of the 5-HT1A receptor agonist flesinoxan, Eur J Pharmacol, vol. 445, no. 1-2, pp. 43-54. DOI
2001
Vis, P., Della Pasqua, O., Kruk, M., Martin, D., Mocaer, E., Danhof, M., Jochemsen, R. , Population pharmacokinetic-pharmacodynamic modelling of S 15535, a 5-HT(1A) receptor agonist, using a behavioural model in rats, Eur J Pharmacol, vol. 414, no. 2-3, pp. 233-43. DOI
1999
Snoeck, E., Jacqmin, P., Van Peer, A., Danhof, M. , A combined specific target site binding and pharmacokinetic model to explore the non-linear disposition of draflazine, J Pharmacokinet Biopharm, vol. 27, no. 3, pp. 257-81.
1998
Snoeck, E., Ver Donck, K., Jacqmin, P., Van Belle, H., Dupont, A.G., Van Peer, A., Danhof, M. , Physiological red blood cell kinetic model to explain the apparent discrepancy between adenosine breakdown inhibition and nucleoside transporter occupancy of draflazine, J Pharmacol Exp Ther, vol. 286, no. 1, pp. 142-9.
1996
Snoeck, E., Jacqmin, P., Van Peer, A., Danhof, M., Ver Donck, K., Van Belle, H., Woestenborghs, R., Crabbe, R., Van Gool, R., Dupont, A., Heykants, J. , The implications of non-linear red blood cell partitioning for the pharmacokinetics and pharmacodynamics of the nucleoside transport inhibitor draflazine, Br J Clin Pharmacol, vol. 42, no. 5, pp. 605-13.